Redirecting anti-Vaccinia virus T cell immunity for cancer treatment by AAV-mediated delivery of the VV B8R gene

Immunotherapies, such as immune checkpoint inhibitors (ICIs) and chimeric antigen receptor-T (CAR-T) cells, are only efficient in a small proportion of tumor patients. One of the major reasons for this is the lack of immune cell infiltration and activation in the tumor microenvironment (TME). Recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Dujuan, Song, Qianqian, Li, Junqi, Chard Dunmall, Louisa S., Jiang, Yuanyuan, Qin, Bin, Wang, Jianyao, Guo, Haoran, Cheng, Zhenguo, Wang, Zhimin, Lemoine, Nicholas R., Lu, Shuangshuang, Wang, Yaohe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114156/
https://www.ncbi.nlm.nih.gov/pubmed/35615262
http://dx.doi.org/10.1016/j.omto.2022.04.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114156/
https://www.ncbi.nlm.nih.gov/pubmed/35615262
http://dx.doi.org/10.1016/j.omto.2022.04.008

Ejemplares similares